ProKidney Corp.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG7S53R1049
USD
2.57
0.32 (14.22%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
ProKidney Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
No of Months
12
12
12
12
Profit Before Tax
-163.00
-129.00
-147.00
-55.00
Adjustment
0.00
0.00
0.00
0.00
Changes In working Capital
3.00
16.00
-6.00
2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-126.00
-90.00
-77.00
-50.00
Cash Flow from Investing Activities
20.00
-329.00
-1.00
-5.00
Cash Flow from Financing Activities
144.00
-9.00
548.00
71.00
Net Cash Inflow / Outflow
38.00
-429.00
469.00
15.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of ProKidney Corp.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-163.933
-125.771
-38.00
-30.34%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
3.956
-65.509
68.00
106.04%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-126.351
-148.609
22.00
14.98%
Cash Flow from Investing Activities
20.414
142.293
-122.00
-85.65%
Cash Flow from Financing Activities
144.408
-90.372
234.00
259.79%
Net Cash Inflow / Outflow
38.471
-96.689
134.00
139.79%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-0.001
0.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -40.28% vs -16.84% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-126.35
-90.07
-40.28%